Circulating matrix metalloproteinase-9 is transiently elevated after colorectal surgery

被引:16
作者
de Hingh, IHJT [1 ]
Waas, ET [1 ]
Lomme, RMLM [1 ]
Wobbes, T [1 ]
Hendriks, T [1 ]
机构
[1] Univ Med Ctr Nijmegen, Dept Surg, NL-6500 HB Nijmegen, Netherlands
关键词
colorectal cancer; gelatinase; MMP-2; MMP-9; patient; plasma; surgery;
D O I
10.1007/s00384-004-0578-4
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and aims. Plasma levels of matrix metalloproteinases (MMPs) may yield important information in patients suffering from colorectal cancer but the effect of surgery, a common treatment modality in these patients, on circulating MMP levels is currently unknown. The aim of this study was to assess whether plasma MMP-2 and MMP-9 levels are affected by operative procedures. Materials and methods. In total 128 patients undergoing elective surgery for colorectal cancer (n=66), liver metastases from colorectal origin (n=50) and arthrosis of the hip (n=12) were included in the study. Gelatinase activity was measured, using quantitative gelatin zymography, in plasma obtained before operation and 1 week, 1 month and 3 months postoperatively. Results. One week after operation a significant increase in proMMP-9 activity was measured after colorectal surgery (260%, p =0.0038), liver surgery (285%, p <0.0001) and hip surgery (217%, p =0.012) as compared with preoperative levels. After 1 month proMMP-9 activity had returned to preoperative levels. No effect on proMMP-2 activity was measured. Conclusion. Operative procedures have a profound but transient effect on plasma MMP-9 activity. If used to assess disease status, postoperative plasma MMP levels should be interpreted with caution.
引用
收藏
页码:446 / 450
页数:5
相关论文
共 18 条
[1]  
Ågren MS, 1998, BRIT J SURG, V85, P68
[2]   The plasminogen activator and matrix metalloproteinase systems in colorectal cancer: relationship to tumour pathology [J].
Baker, EA ;
Leaper, DJ .
EUROPEAN JOURNAL OF CANCER, 2003, 39 (07) :981-988
[3]   Matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1 and tumour necrosis factor α release during cardiopulmonary bypass [J].
Galley, HF ;
Macaulay, GD ;
Webster, NR .
ANAESTHESIA, 2002, 57 (07) :659-662
[4]  
Holten-Andersen MN, 2000, CLIN CANCER RES, V6, P4292
[5]   Cardiopulmonary bypass induces the synthesis and release of matrix metalloproteinases [J].
Joffs, C ;
Gunasinghe, HR ;
Multani, MM ;
Dorman, BH ;
Kratz, JM ;
Crumbley, AJ ;
Crawford, FA ;
Spinale, FG .
ANNALS OF THORACIC SURGERY, 2001, 71 (05) :1518-1523
[6]  
Kolomecki K, 2001, NEOPLASMA, V48, P116
[7]   Analytical aspects regarding the measurement of metalloproteinases and their inhibitors in blood [J].
Lein, M ;
Nowak, L ;
Jung, K ;
Koenig, F ;
Lichtinghagen, R ;
Schnorr, D ;
Loening, SA .
CLINICAL BIOCHEMISTRY, 1997, 30 (06) :491-496
[8]   Inflammatory cytokines and cell response in surgery [J].
Lin, E ;
Calvano, SE ;
Lowry, SF .
SURGERY, 2000, 127 (02) :117-126
[9]   Cardiac surgery increases the activity of matrix metalloproteinases and nitric oxide synthase in human hearts [J].
Mayers, I ;
Hurst, T ;
Puttagunta, L ;
Radomski, A ;
Mycyk, T ;
Sawicki, G ;
Johnson, D ;
Radomski, MW .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2001, 122 (04) :746-752
[10]  
Mysliwiec Angela G, 2002, Clin Colorectal Cancer, V1, P208, DOI 10.3816/CCC.2002.n.002